Tissue Regenix Plc of the UK said that a preclinical study of its tissue regeneration technology showed a better performance than a competitor bovine-derived matrix. The study results were published in the open-access journal, PLoS. ---Subscribe to MedNous to access this article--- Company News Regenerative Medicine
